OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn
Michael Miller, Deepak L. Bhatt, Eliot A. Brinton, et al.
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 7
Michael Miller, Deepak L. Bhatt, Eliot A. Brinton, et al.
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 7
Showing 7 citing articles:
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society
Juan Pedro‐Botet, Francisco Arrieta, Manuel Botana, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2025), pp. 101523-101523
Closed Access
Juan Pedro‐Botet, Francisco Arrieta, Manuel Botana, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2025), pp. 101523-101523
Closed Access
Impact of Lipid and ASCVD-Modulating Agents on Glycemia and New-Onset Diabetes or Prediabetes
Om P Ganda
JACC Advances (2025), pp. 101700-101700
Open Access
Om P Ganda
JACC Advances (2025), pp. 101700-101700
Open Access
Concept and practice in the use of high-dose eicosapentaenoic acid for cardiovascular disease prevention in hypertriglyceridaemia
Guillaume Roger, Chris J. Packard, L. Masana, et al.
Heart (2025), pp. heartjnl-325765
Closed Access
Guillaume Roger, Chris J. Packard, L. Masana, et al.
Heart (2025), pp. heartjnl-325765
Closed Access
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease
Michael Miller
Current Opinion in Cardiology (2024)
Open Access | Times Cited: 3
Michael Miller
Current Opinion in Cardiology (2024)
Open Access | Times Cited: 3
Metabolic syndrome cardiovascular risk prevention by omega-3 polyunsaturated fatty acids
Magnus Bäck, Roberto Latini
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 1
Magnus Bäck, Roberto Latini
European Heart Journal Open (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 1
Terapia farmacológica hipolipemiante para la reducción del riesgo cardiovascular en la diabetes. Visión clínica del Grupo de Trabajo de Enfermedad Cardiovascular de la Sociedad Española de Diabetes
Juan Pedro‐Botet, Francisco Arrieta, Manuel Botana, et al.
Endocrinología Diabetes y Nutrición (2024)
Closed Access
Juan Pedro‐Botet, Francisco Arrieta, Manuel Botana, et al.
Endocrinología Diabetes y Nutrición (2024)
Closed Access
Editors’ highlight picks from 2023 in EHJ Open
Magnus Bäck, Maciej Banach, Frieder Braunschweig, et al.
European Heart Journal Open (2023) Vol. 4, Iss. 1
Open Access
Magnus Bäck, Maciej Banach, Frieder Braunschweig, et al.
European Heart Journal Open (2023) Vol. 4, Iss. 1
Open Access
